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Mycobacterium tuberculosis (Mtb) has a highly complex cell wall, which is required for both bacte-
rial survival and infection. Cell wall biosynthesis is dependent on decaprenyl diphosphate as a glyco-
carrier, which is hence an essential metabolite in this pathogen. Previous biochemical studies
indicated (E)-geranyl diphosphate (GPP) is required for the synthesis of decaprenyl diphosphate.
Here we demonstrate that Rv0989c encodes the ‘‘missing’’ GPP synthase, representing the ﬁrst such
enzyme to be characterized from bacteria, and which presumably is involved in decaprenyl diphos-
phate biosynthesis in Mtb. Our investigation also has revealed previously unrecognized substrate
plasticity of the farnesyl diphosphate synthases fromMtb, resolving previous discrepancies between
biochemical and genetic studies of cell wall biosynthesis.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mycobacterium tuberculosis (Mtb) is the main intracellular path-
ogen responsible for the human disease Tuberculosis, which is par-
ticularly lethal in immune-deﬁcient individuals. Evolution of drug
resistant strains has renewed this pathogen’s threat on the general
population, as these new strains are extremely pathogenic and
untreatable by current antibiotic regimens [1]. Furthermore, dec-
ades of research have failed to uncover the pathogenic mechanism
of Mtb, complicating drug design efforts. This elusive mechanism
likely involves a multifactorial attack, employing attack by a vari-
ety of virulence factors over the course of the infection [2]. One
set of these virulence factors involve the complex mycobacterial
cell wall and lipids, which have been linked to pathogenesis and
survival of the bacteria during infection [3].
The mycobacterial cell wall is unique amongst bacteria. The cell
wall consists of the peptidoglycan, arabinogalactan, and mycolipidchemical Societies. Published by E
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components [4]. Important in proper assembly of this complex
structure is the glyco-carrier polyprenyl phosphate (Pol-P) [5].
Such Pol-P molecules are synthesized via the addition of isoprene
units in the form of isopentenyl diphosphate (IPP) to a variety of
allylic isoprenyl diphosphate acceptors, which are found in varying
lengths, as well as various double bond isomers. Speciﬁcally, Mtb
utilizes a 10 isoprene-unit decaprenyl diphosphate to assemble
its complex cell wall [6], which is formed by the addition of seven
IPP to (Z,E)-farnesyl diphosphate (FPP) by Rv2361c [7]. To synthe-
size (Z,E)-FPP, one unit of IPP is added to (E)-geranyl diphosphate
(GPP) by Rv1086 [7]. Previous work has indicated that this process
is dependent on GPP as the allylic acceptor of IPP, yet no GPP
synthase has been characterized from Mtb [8] (Fig. 1). In addition,
while Rv2361c is essential for bacterial survival [9], neither Rv1086
nor the remaining uncharacterized prenyltransferases are similarly
essential, complicating identiﬁcation of the prenyltransferases in-
volved in decaprenyl diphosphate biosynthesis.
While studying the biosynthesis of the immune modulating dit-
erpenoid, isotuberculosinol, we uncovered four previously unchar-
acterized putative trans-prenyltransferases (Rv0989c, Rv2173,
Rv3383c, Rv0562) [10]. Of these prenyltransferases, only Rv0989c
failed to synthesize the (E,E,E)-geranylgeranyl diphosphate (GGPP)
required for isotuberculosinol or other diterpenoid biosynthesis.
These initial assays were not set up to detect shorter chain isopre-
noids (i.e. FPP or GPP), leading to a lack of observed activity with
Rv0989c. After recognizing that a GPP synthase was expected, welsevier B.V. All rights reserved.
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Fig. 1. Decaprenyl diphosphate biosynthesis in Mycobacterium tuberculosis. The
roles of Rv1086 and Rv2361c have been demonstrated, yet biochemical analysis
indicated they are dependent on a previously uncharacterized GPP synthase, which
is demonstrated here to be encoded by Rv0989.
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isoprenoids, and found that Rv0989c acts as a GPP synthase, that
seems to assist the production of FPP in Mtb. Furthermore, our
analysis indicates that Rv1086 is able to produce small amounts
of (Z,E)-FPP from dimethylallyl diphosphate (DMAPP), which may
explain the non-essential nature of these prenyltransferases.
Accordingly, we describe here the ﬁrst bacterial GPP synthase,
and further clarify the roles of the various isopentyl diphosphate
synthases involved in production of the decaprenyl diphosphate
required for mycobacterial cell wall biosynthesis, thus resolving
the apparent contradictions between biochemical and genetic
analysis of these enzymes.
2. Materials and methods
2.1. General
IPP, DMAPP, GPP, (E,E)-FPP, and GGPP were purchased from Iso-
prenoids, LC (Tampa, FL). Corresponding dephosphorylated alcohol
standards for gas chromatography (GC) analysis were purchased
from Sigma–Aldrich (St. Louis, MO). Unless otherwise noted, all
other chemicals were purchased from Fisher Scientiﬁc (St. Louis,
MO) and all molecular biology reagents were purchased from Invit-
rogen (Carlsbad, CA). Sequence alignments were carried out using
the AlignX program from the Vector NTI software package (Invitro-
gen), using standard parameters.
2.2. Cloning, expression, and puriﬁcation
Rv0989c and Rv3398c were cloned from Mtb CDC1551, while
Rv1086 was obtained as a synthetic construct, codon-optimized
for expression in Escherichia coli. These were cloned into pENTR/
SD/D-TOPO prior to directional recombination into an expression
vector containing a 6xHis N-terminal fusion (pDEST17, Gateway,
Invitrogen). Proteins were expressed in E. coli strain C41 (Lucigen,
Middleton, WI), by growing the recombinant bacteria in NZY liquid
media at 37 C to an OD600 of 0.6, transfer to 16 C for 1 h prior to
induction with 0.5 mM IPTG, and subsequent 14–16 h fermenta-
tion. Cells were harvested via centrifugation and resuspended in
Lysis Buffer (10 mM Tris–Cl, 10% Glycerol, 1 mM dithiothreitol)
for sonication. The resulting lysates were clariﬁed via centrifuga-
tion (10 min  10,000g). The recombinant proteins were then
puriﬁed over Ni-NTA Superﬂow resin (Novagen) following manu-
facturer protocols.2.3. Prenyltransferase assay
The puriﬁed enzymes were characterized in Assay Buffer
(50 mM sodium phosphate (pH 7.0), 10% glycerol, 5 mM MgCl2,
2 mM dithiothreitol), with IPP and allylic isoprenyl diphosphate
substrate (i.e. DMAPP, GPP, or FPP), in a ﬁnal volume of 1 ml at
37 C. Assays were stopped by the addition of 1 ml of Stopping
Solution (9:1 methanol:3 N hydrochloric acid), which also dephos-
phorylates the substrates and products, and 1 ml of pentane was
added immediately and mixed to allow for full partitioning of
the isoprenoid alcohols to the organic solvent layer. This was re-
moved and dried under a stream of N2 at room temperature prior
to resuspension in 50 ll hexanes. Enzymatic products were identi-
ﬁed on a gas chromatograph (GC) with mass spectrometry (MS)
detection using a Varian 3900 GC with Saturn 2100T ion-trap MS
(Varian Inc, Palo Alto, CA) with comparison to authentic standards,
and were quantiﬁed via an Agilent 6890 GC with ﬂame ionization
detection (FID)(Agilent Technologies, Santa Clara, CA), using a pre-
viously published method [11].
2.4. Characterization of Rv0989c
Rv0989c was determined to produce GPP, and then assays with
this enzyme optimized for protein concentration and incubation
time to obtain initial linear reaction rates. It was necessary to use
P0.5 lM enzyme to achieve linearity, with incubation times of
2 min then found to be optimal. Steady-state kinetic constantswere
determined by varying concentrations of either substrate, i.e. 10–
300 lM IPP or 5–200 lM DMAPP, with the other held constant at
the highest relevant concentration, which initial analysis had deter-
mined was saturating. Concentrations of both the internal standard
(cembrene) and product were determined by integration of peaks
after separation and detection by GC-FID. The observed data was
ﬁt to the Michaelis–Menten equation (KaleidaGraph 4.0, Synergy
Software; Reading, PA), resulting in R-valuesP0.97.
2.5. Coupled assays
Coupled assays were carried out by pre-incubating Rv0989c
(5 lM) with DMAPP (100 lM) and IPP (100 lM) for 5 min. prior
to the addition of Rv1086 (1 lM) or Rv3398c (0.35 lM), along with
an additional 50 lM IPP, and the assay incubated for an additional
5 min before stopping. Control assays with Rv1086 or Rv3398c, in
the absence of Rv0989c, using 100 lM of GPP or DMAPP as the
allylic substrate, were run for 5 min. These all were analyzed by
GC–MS, as described above, for production of the relevant isomers
of FPP using separate methods, allowing for distinct separation of
the resulting dephosphorylated farnesol (i.e. (E,E)-farnesol [12] or
(Z,E)-farnesol [11]).
2.6. Characterization of Rv3398c and Rv1086
Rv3398c was kinetically characterized as described above for
Rv0989c, using substrate concentrations ranging from 2.5 to
200 lM. Time course studies with Rv1086 were performed with
100 lM each of IPP and DMAPP. When Rv1086 was assayed alone,
Triton X-100 was added at 0.3% (v/v) to the Assay Buffer to mimic
previously reported conditions [8].
3. Results
3.1. Characterization of Rv0989c as a GPP synthase
Rv0989c was initially screened for GGPP synthesis based on its
homology to other GGPP synthases within the Mtb genome
F.M. Mann et al. / FEBS Letters 585 (2011) 549–554 551(Rv0562, Rv2173, Rv3383c) [10]. As Rv0989c failed to synthesize
GGPP from any allylic precursor (DMAPP, GPP, or FPP), it was then
assessed for activity as a GPP or FPP synthase, and found to pro-
duce GPP when incubated with DMAPP and IPP (Fig. 2). Although
production of (E,E)-FPP was occasionally observed in the presence
of excess (>1 mM) substrate, this likely indicates non-physiologi-
cally relevant reuptake of product for further elongation under
these conditions. Steady-state kinetic analysis of Rv0989c revealed
unusual behavior. When varying DMAPP concentration in the pres-
ence of saturating amounts of IPP, kcat appeared to be 0.7 min1,
which is over 7.5-fold lower than that measured when varying
IPP concentration in the presence of saturating amounts of DMAPP,
where kcat appeared to be 5.1 min1. Yet the pseudo-substrate
binding constant KM suggests DMAPP is bound threefold tighter
than IPP (58 versus 163 lM, respectively). This may indicate
non-catalytically relevant binding of two molecules of IPP at high
concentrations, necessitating displacement by DMAPP that de-
creases the observed catalytic rate.
3.2. Rv0989c facilitates production of (Z,E)-FPP by Rv1086 and
(E,E)-FPP by Rv3398c
Decaprenyl diphosphate formation in Mtb proceeds through
Rv1086, a (Z,E)-FPP synthase, which has been reported to use
exclusively GPP as its allylic isoprenyl diphosphate substrate [8].
Similarly, Rv3398c, the Mtb (E,E)-FPP synthase, also has been re-
ported to utilize GPP exclusively [13]. To demonstrate that
Rv0989c synthesizes the required product for further elaboration
into these important isoprenyl diphosphates, Rv0989c was assayed
with each of these FPP synthases. Coupled assays with Rv0989c
and Rv1086 led to production of signiﬁcant amounts of (Z,E)-FPP
(Fig. 3), along with smaller amounts (<10%) of (E,E)-FPP (data not
shown). Surprisingly, a small amount of (Z,E)-FPP also was pro-
duced by Rv1086 from IPP and DMAPP in the absence of Rv0989
(Fig. 3). Nevertheless, time course measurements indicate the cou-
pled reaction proceeds at a faster rate and nets higher yields of
(Z,E)-FPP (Fig. 4), supporting a role for GPP as the preferred sub-
strate for this enzyme. Coupled assays with Rv0989c and
Rv3398c produce (E,E)-FPP (Fig. 5). However, again, when assayed5x103
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Fig. 2. Conﬁrmation of Rv0989c activity. Comparison of dephosphorylated Rv0989c pronly in the presence of DMAPP and IPP, Rv3398c is able to produce
(E,E)-FPP at measureable rates. Steady state kinetic analysis of
Rv3398c determined that kcat is 1.5 ± 0.1 min1, KM for IPP is
2.6 ± 0.4 lM, while that for DMAPP is 20 ± 9 lM. Comparing to pre-
vious publications [13], this still suggests that GPP (KM = 10 lM) is
the preferred allylic isoprenyl diphosphate substrate for Rv3398c.
4. Discussion
The mycobacterial cell wall has been extensively studied as it is
exceptionally reinforced and uniquely immunogenic [3]. Key to the
assembly of this complex structure is the glyco-carrier decaprenyl
diphosphate [6]. Though clearly required for cell growth, develop-
ment, and viability [9], the biosynthetic pathways utilized in syn-
thesis of decaprenyl diphosphate have frustrated scientists in
recent decades. Genetic and biochemical analysis of the biosyn-
thetic machinery has failed to completely characterize the path-
way. While decaprenyl diphosphate production is required for
cell wall biosynthesis [14], genetic analysis indicates that only
the ﬁnal step in the production of this important metabolite (that
catalyzed by the gene product of Rv2361c) is absolutely required
for bacterial viability [9]. While this decaprenyl diphosphate syn-
thase will accept a range of allylic isoprenyl diphosphate sub-
strates [7], it has been reported that the production of its
preferred (Z,E)-FPP primer for elongation is completely dependent
on the availability of GPP [8]. Previously, neither genetic nor bio-
chemical analysis was able to identify the corresponding GPP syn-
thase in Mtb, which our results now demonstrate is encoded by
Rv0989c.
To the best of our knowledge, Rv0989c is the ﬁrst characterized
bacterial GPP synthase. While this does exhibit homology to other
such trans-prenyltransferases, there are a number of surprising
substitutions observed in Rv0989c. In particular, while readily
aligned with other known GPP synthases (Fig. 6), Rv0989c contains
remarkable changes within two otherwise well-conserved aspar-
tate-rich motifs (designated as the ﬁrst and second, ﬁrst aspar-
tate-rich motif (FARM) and second aspartate-rich motif (SARM),
respectively). In Rv0989c, the second aspartate of the FARM and
the ﬁrst aspartate of the SARM are replaced by arginine, and thex103
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Fig. 3. Production of (Z,E)-FPP-derived FOH by Rv0989c/Rv1086. GC–MS analysis of product proﬁles from Rv1086 assayed in the presence of authentic GPP, GPP synthesized
by Rv0989c, or DMAPP. (A) Total ion chromatograms. (B) Mass spectra.
Fig. 4. Time-dependent production of (Z,E)-FPP by Rv1086. (Z,E)-FPP-derived FOH
synthesis by Rv1086 assayed in the presence of 100 lM IPP and 100 lM DMAPP
(squares) or 100 lM IPP, 100 lM DMAPP, and Rv0989c (circles). Smooth ﬁt lines
were applied.
552 F.M. Mann et al. / FEBS Letters 585 (2011) 549–554ﬁnal aspartate of the SARM is replaced by an alanine, whereas the
only other naturally found substitutions are asparagines. Indeed,
site-directed mutations in the ﬁrst and second aspartate of theSARM of other trans-prenyltransferases to alanine, speciﬁcally an
(E,E)-FPP synthase from Saccharomyces cerevisiae, have demon-
strated a drastic loss of activity [15]. The signiﬁcance of the ob-
served divergence in the FARM and SARM of Rv0989c is not
readily apparent, but their expected deleterious effects may have
been a contributing factor to the previous difﬁculty in identiﬁca-
tion of a GPP synthase in the Mtb genome.
We have determined Rv0989c is able to provide the GPP pre-
cursor required for efﬁcient production of both double bond iso-
mers of FPP in Mtb, as demonstrated by coupled assays with the
relevant FPP synthases (encoded by Rv1086 and Rv3398c). How-
ever, our enzymatic analysis also revealed that both of these are
able to react with the shorter, universal allylic isoprenyl diphos-
phate substrate DMAPP. This clariﬁes the contradictory bio-
chemical and genetic evidence regarding the decaprenyl
diphosphate biosynthetic pathway in Mtb [8,9,13]. In particular,
knockout analysis of these prenyltransferases in Mtb have dem-
onstrated that they are not required for viability, indicating that
cell wall biosynthesis was able to proceed in their absence,
despite biochemical evidence indicating that decaprenyl diphos-
phate production depends on their activity/products. Neverthe-
less, these ﬁndings further highlight the need for development
and study of functional, non-lethal knockouts in Mtb cell wall
biosynthetic machinery, as many questions have yet to be an-
swered regarding bacterial tolerance and ﬂexibility for substitu-
tions in this process. This important component of Mtb viability
and pathogenesis needs to be completely understood before the
puzzle that is the Mtb pathogenic mechanism will be solved.
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Fig. 5. Production of (E,E)-FPP-derived FOH by Rv0989c/Rv3398c. GC–MS analysis of product proﬁles from Rv3398 assayed in the presence of authentic GPP and GPP
synthesized by Rv0989c. (A) Total ion chromatograms. (B) Mass spectra.
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    AgGPS   (55) Q-VAAVTELVEMLHVASLLIDDIEDNSAWRRGVAAAHVVYGSPMTINTANYMYFVSMS------LLGQLAAQRPAGPLQD
    AtGPS  (161) VRQRGIAEITEMIHVASLLHDDVLDDADTRRGVGSLNVVMGNKMSVLAGDFLLSRACG------ALAALKNTEVVALLAT
    CsGPS   (60) TRQQCIAEITEMIHVASLLHDDVLDDADTRRGIGSLNFVMGNKLAVLAGDFLLSRACV------ALASLKNTEVVTLLAT
    IpGPS  (137) KLSGVLGWCAEIIQAYFCMLDDIMDDSDTRRGKPTWYKLPGIGLNAVTDVCLMEMFTFELLKRYFPKHPSYADIHEILRN
  Rv0989c   (71) WEVTVAGAAIELMHLGTLCHDRVVDESDMSRKTPSDNTRWTNNFAILAGDYRFATAS-------QLASRLDPEAFAVVAE
                 241                                                                          320
    AgGPS  (128) LLKVFNEEMMNLHRGQGLDIYWRDTFTVPSEHDYLRMVMHKTGGLFRLTVRIMEALREGPDGPGS-TLVPLSNLLGVLYQ
    AtGPS  (235) AVEHLVTGETMEITSS--------TEQRYSMDYYMQKTYYKTASLISNSCKAVAVLTGQTAEVAV-LAFEYGRNLGLAFQ
    CsGPS  (134) VVEHLVTGETMQMTTS--------SDQRCSMDYYMQKTYYKTASLISNSCKAIALLAGQTAEVAI-LAFDYGKNLGLAYQ
    IpGPS  (217) LLFLTHMGQGYDFTFIDPVTRKINFNDFTEENYTKLCRYKIIFSTFHNTLELTSAMANVYDPKKIKQLDPVLMRIGMMHQ
  Rv0989c  (144) AFAELITGQMRATRGP--------ASHIDTIEHYLRVVHEKTGSLIAASGQLGAALSGAAEEQIR-RVARLGRMIGAAFE
*  #                                                                      400
    AgGPS  (207) VRDDYLNLTDSRMSENKGFA-----DDITEGKFSYPIIHGLQYARVHDPAGYDFLVSVLR----QRTTDITTKRRVVRYL
    AtGPS  (306) LIDDILDFTGTSASLGKGSL-----SDIRHGVITAPILFAMEEFPQLREVVDQVEKDPRN---VDIALEYLGKSKGIQRA
    CsGPS  (205) LIDDVLDFTGTSASLGKGSL-----SDIRHGIITAPILFAMEEFPQLRTVVEQGFEDSSN---VDIALEYLGKSRGIQKT
    IpGPS  (297) SQNDFKDLYRDQGEVLKQAEKSVLGTDIKTGQLTWFAQKALSICNDRQRKIIMDNYGKEDN-------KNSEAVREVYEE
  Rv0989c  (215) ISRDIIAISGDSATLSG--------ADLGQAVHTLPMLYALREQTPDTSRLRELLAGPIHDDHVAEALTLLRCSPGIGKA
Fig. 6. Alignment of Rv0989c with conﬁrmed GPP synthases. Alignment of the Rv0989c gene product with that of the GPP synthases from Ips pini (IpGPS) [16], Aphis gossypii
(AgGPS) [17], Arabidopsis thaliana (AtGPS) [18], and Citrus sinensus (CsGPS) [19]. The ﬁrst- and second aspartate-rich motifs (FARM and SARM, respectively), are underlined,
with the non-canonical substitution of arginine or alanine residues for otherwise conserved active site aspartate residues in Rv0989c indicated by ⁄ and # above the relevant
position, respectively.
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